Adagio Therapeutics Inc (ADGI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.64 +0.04 (+0.87%) 09/12/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.64 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2011 | 12-2010 | 09-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | 24,856 | -8,307 |
| Depreciation Amortization | N/A | N/A | N/A | 13 | 328 |
| Accounts receivable | N/A | N/A | N/A | N/A | 1 |
| Other Working Capital | N/A | N/A | N/A | -333 | 1,045 |
| Other Operating Activity | 0 | 0 | 0 | -33,431 | 3,534 |
| Operating Cash Flow | $N/A | $N/A | $N/A | $-8,895 | $-3,399 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -20,000 | N/A |
| Net Acquisitions | N/A | N/A | N/A | 54,446 | 4,213 |
| Other Investing Activity | 0 | 0 | 0 | -15,000 | -1,400 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $19,446 | $2,813 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -1 | -934 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 73 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -6 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -737 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $-1 | $-1,604 |
| Exchange Rate Effect | N/A | N/A | N/A | 850 | 2 |
| Beginning Cash Position | N/A | N/A | N/A | 3,475 | 5,663 |
| End Cash Position | N/A | N/A | N/A | 14,875 | 3,475 |
| Net Cash Flow | $N/A | $N/A | $N/A | $11,400 | $-2,188 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | N/A | -8,895 | -3,399 |
| Free Cash Flow | 0 | 0 | 0 | -8,895 | -3,399 |